Search PubMed⌕ Search

PubMed · 7002298

Ventricular ectopy and sudden death.

Abstract

The occurrence of certain complex forms of chronic ventricular arrhythmias or high frequency of less complex forms constitutes an independent risk factor for subsequent sudden death proportional to the degree of host organic heart disease. Currently, grade is probably best defined by referring to either simple or complex ventricular arrhythmias--complex forms being a combination of Lown's modified grades 3, 4, and 5, plus bigeminy. Frequency may provide an equally good expression of the information contained in gradation analysis, but one must recognize the potentially important transient advanced grades which may occur when overall frequency is low. The importance of such transient events has not yet been determined. The recently emphasized problem of spontaneous variation of frequency has yet to be resolved, both in terms of the patient who is not on drug therapy and those who are on long-term, steady-state therapy. For purposes of risk assessment for sudden death, until some of the controversies mentioned are resolved, the best compromise between accuracy, limitations, and economics remains the use of a single 24-hour Holter monitor analyzed for both frequency and the occurrence of complex or advanced grades. The goal of treatment should be a marked reduction or abolition of chronic VPDs, but if this is not successful, simply maintaining therapeutic blood levels of antiarrhythmic drugs may afford some protection against symptomatic or potentially lethal arrhythmias. The roles of provocative testing employing exercise, psychologic stressing, or electrophysiologic testing to identify high risk individuals are all being intensively investigated at the present time.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Rozanski, A Castellanos, R J Myerburg. 1980. Ventricular ectopy and sudden death.. https://pubmed.ncbi.nlm.nih.gov/7002298/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Inflammation in variant angina: is there any evidence?

Variant angina, defined as spontaneous angina pectoris associated with transient ST-segment elevation, has proved to be caused usually by episodic coronary spasm since Prinzmetal and his associates described a form of angina quite different from classic Heberden angina pectoris in 1959. Currently, coronary artery spasm is defined as reversible coronary stenosis, which limits coronary blood flow under resting conditions, and it plays an important role in ischemic heart disease, particularly in variant angina. Data available in respect of coronary vasospasm showed that it is closely related to atherosclerotic coronary artery disease, since intravascular ultrasound studies reveal atherosclerotic plaques in almost any spastic segment. Risk factors for coronary artery disease and coronary vasospasm, however, differ profoundly. Cigarette smoking is the only established risk factor. Although several candidates and predisposing factors, such as serotonin, histamine, thromboxane, and endothelin, have been described, the mediators and the pathogenesis of the disease remain unknown. There are abundant studies that inflammation plays an important role in the initiation, development as well as evolution of atherosclerosis, suggesting that atherosclerosis is an inflammation disease. The evidence regarding the role of inflammatory pathways in different clinical entities of coronary artery disease has significantly been accumulated. And also, primary studies have showed that inflammation may be a contributor for variant angina or vasospastic coronary disease is at least partially driven by inflammation. Although much more research is obviously needed, primary evidence provide us with some direction for that research.

Angina Pectoris, Variant↗

Coronary artery stent placement as a treatment of acute coronary syndrome in course of variant angina.

High doses of calcium antagonists and nitrates are the treatment of choice in vasospasm angina when no stenosis or mild stenosis is present. In ca. 5-30% patients this kind of treatment is not effective. We present five cases of variant angina with acute coronary syndrome in patients despite standard pharmacological treatment. These patients also did not respond for intracoronary nitroglycerine injection. They were successfully treated with stent implantation in place of vasospasm. Our observations indicate that early enough interventional treatment prevent myocardial infarction. In one case in which stent placement was performed 12 h after clinical manifestation myocardial infarction with Q waves and enzymes release occurred. In others, accurately treated with stent implantation, coronary spasm did not produce myocardial damage. We did not see any clinical and biochemical evidence of myocardial infarction.

Angina Pectoris, Variant↗

Variations in presentation and various options in management of variant angina.

Patients with variant angina represent a diagnostic and therapeutic dilemma. Variant angina is a disease with various causes, variations in treatment guidelines and variable prognosis. In an era of robotic cardiac surgery and automatic cardioverter defibrillators, it is regrettable that we lack enough information on the optimal management of this entity. Lack of randomised trials and a tendency for spontaneous remissions makes interpretation of results difficult. We review the pathophysiology, presentation and recent developments in medical and surgical management of variant angina. Literature is full of conflicting data and it is difficult to make specific recommendations.

Angina Pectoris, Variant↗